There are 2137 resources available
LBA14 - De-escalated neoadjuvant T-DM1 with or without endocrine therapy (ET) vs trastuzumab+ET in early HR+/HER2+ breast cancer (BC): ADAPT-TP survival results
Presenter: Nadia Harbeck
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
165MO - Patient (pt) preference for the pertuzumab-trastuzumab fixed-dose combination for subcutaneous use (PH FDC SC) in HER2-positive early breast cancer (EBC): Primary analysis of the open-label, randomised crossover PHranceSCa study
Presenter: Joyce O'Shaughnessy
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
166MO - A phase III trial to compare the efficacy, safety, pharmacokinetics and immunogenicity of HD201 to trastuzumab in HER2+ early breast cancer patients (TROIKA)
Presenter: Pivot Xavier
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
167MO - Longitudinal evaluation of serum assessed non-adherence to tamoxifen (TAM) among premenopausal patients (pts) in the prospective multicenter CANTO cohort
Presenter: Barbara Pistilli
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
168MO - GeparX: Denosumab (Dmab) as add-on to different regimen of nab-paclitaxel (nP)-anthracycline based neoadjuvant chemotherapy (NACT) in early breast cancer (BC): Subgroup analyses by RANK expression and HR status
Presenter: Theresa Link
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
169MO - Development and validation of a magnetic resonance imaging radiomics-based signature to predict axillary lymph node metastasis and disease-free survival in patients with breast cancer: A multicenter cohort study
Presenter: Herui Yao
Session: Mini Oral - Breast cancer, early stage
Resources:
Abstract
Slides
Webcast
886MO - Health-related quality of life (HRQoL) from KEYNOTE-204: A phase III, randomized, open-label study of pembrolizumab (pembro) vs brentuximab vedotin (BV) in relapsed or refractory classical Hodgkin lymphoma (R/R cHL)
Presenter: Pier Luigi Zinzani
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
887MO - Real-world treatment management of patients with advanced-stage classic Hodgkin lymphoma receiving front line therapy
Presenter: Abraham Avigdor
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
888MO - Effectiveness of brentuximab vedotin in relapsed/refractory classic Hodgkin lymphoma: A systematic review and meta-analysis
Presenter: Bastian von Tresckow
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast
889MO - Long-term follow-up of patients with nodular lymphocyte predominant Hodgkin lymphoma: A report from the Spanish Lymphoma Oncology Group
Presenter: Beatriz Nunez Garcia
Session: Mini Oral - Haematological malignancies
Resources:
Abstract
Slides
Webcast